RGH 1876

Drug Profile

RGH 1876

Alternative Names: GYKI 39484

Latest Information Update: 08 Nov 2006

Price : $50

At a glance

  • Originator Gedeon Richter; Nonindustrial source
  • Class Antithrombotics; Small molecules
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Thrombosis

Most Recent Events

  • 08 Nov 2006 Discontinued - Preclinical for Thrombosis in Hungary (PO)
  • 09 Jun 1999 A preclinical study has been added to the Thromboses pharmacodynamics section
  • 05 May 1999 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top